DNase I serves as a positive control of antimetastatic action; for this reason, only the DNase I dose, which was the most effective in the B16 melanoma model (50 U/mouse, corresponds to 1.25 mg/kg), was used [20]. The gene discussed is DNASE1; the disease is melanoma.